Zoetis Inc.
ZTSAPI behind this page
ZTS Q3 2025 request
Playground key active
/api/financials?ticker=ZTS&year=2025&quarter=3
Pick an endpoint and run the request.Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Revenue | 2,400 | 2,388 | +0.5% |
Show Product Lines breakouts |
|||
| Animal health diagnostics | 110 | 101 | +8.9% |
| Anti-infectives | 284 | 274 | +3.6% |
| Cattle | 399 | 391 | +2.0% |
| Companion Animal [Member] | 1,652 | 1,609 | +2.7% |
| Companion Animal [Member] · International | 583 | 541 | +7.8% |
| Companion Animal [Member] · U.S. | 1,069 | 1,068 | +0.1% |
| Contract manufacturing & human health | 23 | 21 | +9.5% |
| Dermatology | 472 | 453 | +4.2% |
| Dogs and Cats | 1,586 | 1,551 | +2.3% |
| Fish | 78 | 70 | +11.4% |
| Horses | 66 | 58 | +13.8% |
| Livestock [Member] | 725 | 758 | -4.4% |
| Livestock [Member] · International | 472 | 480 | -1.7% |
| Livestock [Member] · U.S. | 253 | 278 | -9.0% |
| Manufactured Product Other | 31 | 27 | +14.8% |
| Medicated Feed Additives | 5 | 91 | -94.5% |
| Other Non Pharmaceuticals [Member] | 64 | 62 | +3.2% |
| Other pharmaceutical | 178 | 169 | +5.3% |
| Pain and sedation | 204 | 219 | -6.8% |
| Parasiticides | 564 | 530 | +6.4% |
| Poultry | 106 | 139 | -23.7% |
| Swine [Member] | 111 | 131 | -15.3% |
| Total products and services | 2,377 | 2,367 | +0.4% |
| Vaccines | 496 | 468 | +6.0% |
Show Business Segments breakouts |
|||
| International · Operating Segments | 252 | 234 | +7.7% |
| International · Operating Segments | 1,055 | 1,021 | +3.3% |
| U.S. · Operating Segments | 1,322 | 1,346 | -1.8% |
Show Geography breakouts |
|||
| AU | 87 | 83 | +4.8% |
| BR | 100 | 101 | -1.0% |
| CA | 70 | 66 | +6.1% |
| CL | 29 | 31 | -6.5% |
| CN | 45 | 61 | -26.2% |
| DE | 62 | 57 | +8.8% |
| ES | 38 | 35 | +8.6% |
| FR | 40 | 36 | +11.1% |
| GB | 82 | 80 | +2.5% |
| IT | 35 | 31 | +12.9% |
| JP | 34 | 33 | +3.0% |
| MX | 41 | 39 | +5.1% |
| Other developed markets | 164 | 148 | +10.8% |
| Other emerging markets | 228 | 220 | +3.6% |
| Total geographical area | 2,377 | 2,367 | +0.4% |
| US | 1,322 | 1,346 | -1.8% |
| Cost of Revenue | 683 | 701 | -2.6% |
Show Business Segments breakouts |
|||
| International · Operating Segments | 331 | 321 | +3.1% |
| U.S. · Operating Segments | 222 | 258 | -14.0% |
| Selling, General & Administrative | 579 | 565 | +2.5% |
| Research And Development Expense Excluding Acquired In Process Cost | 170 | 167 | +1.8% |
| Amortization Of Intangible Assets Not Associated With Single Function | 32 | 35 | -8.6% |
| Restructuring Charges And Acquisition And Divestiture Related Costs | 4 | 5 | -20.0% |
| Interest Expense | 58 | 57 | +1.8% |
| Non-Operating Income (Expense) | -13 | -16 | +18.8% |
Show Business Segments breakouts |
|||
| International · Operating Segments | 1 | 1 | 0.0% |
| Income Before Taxes | 887 | 874 | +1.5% |
Show Business Segments breakouts |
|||
| All Other Segments | -140 | -137 | -2.2% |
| International · Operating Segments | 556 | 542 | +2.6% |
| U.S. · Operating Segments | 899 | 889 | +1.1% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -306 | -306 | 0.0% |
| Operating Segments | 1,455 | 1,431 | +1.7% |
| Income Tax Expense (Benefit) | 166 | 182 | -8.8% |
| Net Income | 721 | 692 | +4.2% |
Show Equity Components breakouts |
|||
| Retained Earnings | 721 | 682 | +5.7% |
| Net Income | 721 | 682 | +5.7% |
| EPS (Basic) | 1.63 | 1.51 | +7.9% |
| EPS (Diluted) | 1.63 | 1.5 | +8.7% |
| Wtd Avg Shares (Basic) | 442.9 | 452.9 | -2.2% |
| Wtd Avg Shares (Diluted) | 443.2 | 453.5 | -2.3% |
| Gross Profit (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International · Operating Segments | 724 | 700 | +3.4% |
| U.S. · Operating Segments | 1,100 | 1,088 | +1.1% |
| Operating Expenses (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International · Operating Segments | 167 | 157 | +6.4% |
| U.S. · Operating Segments | 201 | 199 | +1.0% |
| Comprehensive Income | 780 | 676 | +15.4% |
| Foreign Currency Transaction Gain Loss Before Tax | 13 | 5 | +160.0% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 2,084 | 1,714 | +21.6% |
| Accounts Receivable | 1,541 | 1,411 | +9.2% |
| Inventory | 2,465 | 2,416 | +2.0% |
| Other Assets Current | 493 | 427 | +15.5% |
| Total Current Assets | 6,583 | 6,282 | +4.8% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 3,600 | 3,298 | +9.2% |
| Operating Lease Right-of-Use Assets | 292 | 223 | +30.9% |
| Goodwill | 2,764 | 2,744 | +0.7% |
Show Geography breakouts |
|||
| International [Member] | 1,249 | 1,229 | +1.6% |
| US | 1,515 | 1,515 | 0.0% |
| Deferred Tax Assets | 587 | 409 | +43.5% |
| Other Non-Current Assets | 293 | 215 | +36.3% |
| Total Assets | 15,159 | 14,357 | +5.6% |
| Intangible Assets | 824 | 972 | -15.2% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Developed Technology Rights | 626 | 767 | -18.4% |
| Other Intangible Assets | 84 | 80 | +5.0% |
| Trademarks And Trade Names | 114 | 125 | -8.8% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 1,040 | 1,186 | -12.3% |
| Current Liabilities | |||
| Accounts Payable | 410 | 404 | +1.5% |
| Other Accrued Liabilities Current | 809 | 725 | +11.6% |
| Employee Related Liabilities Current | 337 | 335 | +0.6% |
| Taxes Payable Current | 152 | 97 | +56.7% |
| Other Liabilities Current | 99 | 115 | -13.9% |
| Total Current Liabilities | 1,807 | 1,702 | +6.2% |
| Non-Current Liabilities | |||
| Long-Term Debt | 7,069 | 6,574 | +7.5% |
| Deferred Tax Liabilities | 147 | 172 | -14.5% |
| Operating Lease Liabilities | 204 | 181 | +12.7% |
| Accrued Income Taxes Noncurrent | 270 | 274 | -1.5% |
| Other Non-Current Liabilities | 264 | 220 | +20.0% |
| Total Liabilities | 9,761 | 9,123 | +7.0% |
| Stockholders' Equity | |||
| Common Stock | 5 | 5 | 0.0% |
| Treasury Stock Value | -8,606 | -6,889 | -24.9% |
| Additional Paid-In Capital | 1,224 | 1,163 | +5.2% |
| Retained Earnings | 13,593 | 11,806 | +15.1% |
| Accumulated Other Comprehensive Income | -818 | -851 | +3.9% |
| Total Stockholders' Equity | 5,398 | 5,234 | +3.1% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 5,398 | 5,234 | +3.1% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent | 72 | 80 | -10.0% |
| Accumulated Net Unrealized Investment Gain Loss | -39 | 13 | -400.0% |
| Accumulated Other Comprehensive Income | -818 | -851 | +3.9% |
| Accumulated Translation Adjustment | -851 | -946 | +10.0% |
| Additional Paid In Capital | 1,224 | 1,163 | +5.2% |
| Common Stock | 5 | 5 | 0.0% |
| Retained Earnings | 13,593 | 11,806 | +15.1% |
| Treasury Stock Common | -8,606 | -6,889 | -24.9% |
| Total Liabilities & Equity | 15,159 | 14,357 | +5.6% |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 366 | 374 | -2.1% |
Show Business Segments breakouts |
|||
| All Other Segments | 38 | 29 | +31.0% |
| International · Operating Segments | 74 | 73 | +1.4% |
| U.S. · Operating Segments | 70 | 65 | +7.7% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 84 | 96 | -12.5% |
| Operating Segments | 144 | 138 | +4.3% |
| Stock-Based Compensation | 61 | 55 | +10.9% |
| Asset Impairment Charges | 39 | 16 | +143.8% |
Show Restructuring Cost And Reserve breakouts |
|||
| Facility Closing | 22 | — | — |
| Gain Loss On Disposition Of Assets1 | 3 | 22 | -86.4% |
| Inventory Write Down | 52 | 71 | -26.8% |
| Deferred Income Taxes | -4 | -186 | +97.8% |
| Cash Received From Payments To Settle Derivative Instruments | 11 | — | — |
| Other Non-Cash Items | -9 | 11 | -181.8% |
| Change in Accounts Receivable | -184 | -134 | -37.3% |
| Change in Inventory | -212 | -113 | -87.6% |
| Increase Decrease In Other Operating Assets | -175 | -14 | -1150.0% |
| Change in Accounts Payable | -30 | 5 | -700.0% |
| Increase Decrease In Other Operating Liabilities | -3 | 36 | -108.3% |
| Increase Decrease In Accrued Taxes Payable | 26 | -10 | +360.0% |
| Net Cash from Operations | 2,011 | 2,048 | -1.8% |
| Investing Activities | |||
| Capital Expenditures | -460 | -439 | -4.8% |
| Payments To Acquire Business Two Net Of Cash Acquired | -10 | -8 | -25.0% |
| Payments To Acquire Investments | -6 | -4 | -50.0% |
| Payments For Proceeds From Hedge Investing Activities | -105 | 11 | -1054.5% |
| Proceeds From Divestiture Of Businesses Net Of Cash Divested | -4 | — | — |
| Proceeds From Sale Of Property Plant And Equipment | 1 | 1 | 0.0% |
| Other Investing Activities | 2 | -2 | +200.0% |
| Net Cash from Investing | -582 | -441 | -32.0% |
| Excise Tax Accrued On Net Share Repurchased Not Paid | 11 | 12 | -8.3% |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 61 | 39 | +56.4% |
| Right Of Use Asset Obtained In Exchange For Finance Lease Liability | 1 | — | — |
| Financing Activities | |||
| Proceeds From Issuance Of Debt | 1,848 | — | — |
| Repayments Of Long Term Debt | -1,350 | — | — |
| Debt Issuance Costs | -14 | — | — |
| Share Based Compensation Related Proceeds Net Of Taxes Paid On Withholding Shares | -12 | -10 | -20.0% |
| Share Repurchases | -1,175 | -1,305 | +10.0% |
| Payments Of Ordinary Dividends | -669 | -592 | -13.0% |
| Proceeds From Payments For Other Financing Activities | -3 | — | — |
| Net Cash from Financing | -1,375 | -1,915 | +28.2% |
| Supplemental | |||
| Income Taxes Paid | 582 | 657 | -11.4% |
| Interest Paid | 225 | 205 | +9.8% |
| Operating Lease Payments | 56 | 46 | +21.7% |
| Finance Lease Principal Payments | 2 | 1 | +100.0% |
| Unpaid Capital Expenditures | 3 | 4 | -25.0% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 43 | -19 | +326.3% |
| Net Change in Cash | 97 | -327 | +129.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2,084 | 1,714 | +21.6% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.